RMC No. 2-2022 — Publishes the full text of letter from the DOH endorsing updates to the List of VAT-Exempt COVID-19 Medicines under RA No. 11534

REPUBLIC OF THE PHILIPPINES

DEPARTMENT OF FINANCE BUREAU OF INTERNAL REVENUE

December 24, 2021

REVENUE MEMORANDUM CIRCULAR NO, 2-2022

SUBJECT : Publishing the Full Text of Letter from the Departmnent of Health (DOH) Endorsing Updates to the List of VAT-Exempt COVII)-19 Medicines Under Republic Act (R.A.) No. 11534

TO : All Internal Revenue Officers and Others Concerned

Grande, Undersecretary of Health for the Health Regulation Team of the DOH, and copy of the updated "List of VAT-Exempt Drugs and Vaccines Prescribed and Iirectly Used for COVID-19 Treatment." concerned, attached is the letter dated December 21, 2021 from Atty. Charade B. Mereado- For the information and guidance of all internal revenue officers, employees and others

as wide a publicity as possible. All concerned are hereby are enjoined to be guided accordingly and give this Circular

1eesau1w BUREAUOS INTERNAL REVENUE JAN 10. 2U22 9:10am TY Commissioner of Internal Revenue CAESAR F. DULAY m 048462

TTAAL

:LDIVISION

Republic of the Philippines Department of Health OFFICE OF THE SECRETARY

REVENUE

21 December 2021 Y2

CAESAR R. DULAY Commissioner Bureau of Internal Revenue JAN 10 2U22 g:ioam A1 Quezon City ChUSaGI.DivISiCm

SUBJECT: Endorsement of the Updated List of VAT-Exempt COVI):1!. Medicines under Republic Act 11534

Dear Commissioner Dulay:

May we respectfully endorse to your good Office the herein attached updated list of VAr-Exempt COVID-19 Drugs under Sec. 5, 109-1, Item (aa) Republic Act (RA) 1153- other-vise knc:wn as the inctuded, delisted and modified under the COVID-19 VAT Exempt List: "Corporate Recovery and Tax Incentives for Enterprises (CREATE)". The follow ing arc ntedicines;

FOR INCLUSION: Anaesthetics -- Local and General Drugs

Ketamine 50 mg/mL, 10 mL Solution for Injectich. Vi: !

Propofol 10 mg/mL, 10 mL Solution for Inject icn, Ar ipnle Propofol 10 mg/mL, 10 mL Solution for Injecr ion, Vi: : Propofol 10 mg/mL, 20 mL Solution for Injection, Ar ipule Propofol Propofol 10 mg/mL, 50 mL 10 mg/mL, 20 mL Solution for Inject.ion, Vi: Solution for Injec ion, Vit

Analgesics (Opiod)

Fentanyl Fentanyl Fentanyl Morphinc Fentanyl Fentanyl Fentanyl Fentanyl Fentanyl Fentanyl 50 mcg/mL,2 mL 50 mcg/hr 300 mcg 100 meg 400 mcg 1o mg 25 mcg/hr 50 mcg/mL, 10 mL 200 mcg 12.5 mcg/hr Sublingual Tablet Solution for Injection, A npu ie Solution for Injection Ampu Modified Release (MR) Tablet Sublingual Tablet Transdermal Patch Sublingual Tablet Transdermal Patch Sublingual Tablct Transdermal Patch

Morphine Morphine 10 mg 10 mg/mL, 1 mL Tablet Solution for Injection, Anpu ie Morphine 16 mg/mL,1 mL Solution for Injection, Ampu te: Morphine Morphine Oxycodone 30 mg 6o mg 10 mg Modified Releasc (M.) Tabl. Capsule Tablet

Building 1, San Laxaro Compound, Rizal Avenue, Sta. Cruz., 1003 Manila - Trunk Line 651.7800 toca,: 1 08+++. 1+:. +I13 Direct Line: 711-9502; 711-9503 Fax: 743-1829 : URL: http:/www.doh.gov.ph; e-majl: f duqu@d 1 :ov.ph

Oxycodone Oxycodone Oxycodone 10 mg 10 mg/mL,1mL 10 img/mL,2 mL Controlled-Relt asc Tablet Solution for Injection. Aap t!. Solution for Iniectio, fuop il.

Oxycodonc Oxycodone 20 mg 15 mg Controlled-Rele asc Tabic:t Controlled-Release Tablet Oxycodone Oxycodone 30 mg 40 mg Controlled-Release T'ablet Controlled-Release T'ablet

Oxycodone Oxycodone 5 mg 5 mg/5 mL, 250 mL Capsule Oral Solution, Bottle

Oxycodone Oxycodone 80 mg 60 mg Controlled-Release Tabiot Controlled-Release Tabiet Anticholinergic

Hyoscine 10 mg Film-Coated Tablet

Hyoscine Hyoscine Hyoscine Hyoscine 5 mg/5 mL, 120 mL 10 mg 20 mg 20 mg/mL,1 mL Tablet Tablet Solution for Injection. Amp. Oral Syrup, Bottle Hyoscine 5 mg/5 mL, 60 mL Oral Syrup, Bottle

Anticonsulvant/Anxiolytics/Hypnotics and Sedatives

Clonazepam Clonazepam 2 mg 500 mcg Tablet Tablet

Diazepam Diazepam Diazepam 5 mg 5 mg/mL, 2 mL 10 mg Tablet Tablet Solution for Inje ction, Arnpi h Midazolam 1 mg/mL,3 mL Solution for Injection, Armpt le Midazolam 1mg/mL,5 mL Solution for Injectior., Arn pt ie Midazolam 1 mg/mL,5 mL Solution for Injection, Vial Midazolam Midazolam 15 mg 15 mg Film-Coated Tablet Tablet Midazolam 5 mg/mL,1 mL Solution for Injection. Ampr 1 Midazolam 5 mg/mL,3 mL Solution for Injectiont. Ampr I3

Antidiuretics / Haemostatics

Vasopressin 20 IU/mL, 1 mL Solution for Injectiorn, Amp te

Antipsychotic / Antivertigo

Haloperidol Haloperidol 20 mg 5 mg Tablet Tablet Haloperidol 5 mg/mL,1 mL Solution for Injectio11, Amp:

Haloperidol 50 mg/mL, 1 mL Solution for Injection, Ampu :

BUREAU OF INTERNALREVENUE

aaNITYN

jAN 10 2022 1o am

.1 Liv.-

Cardiac Drugs

Dobutamine t2.5 mg/mL, 20 mL Solution for Infusion, Vial Dobutamine 25 mg/mL, 10 mL Solution for Injection. Amp i Ie Dobutamine Dopamine Dopamine in 5% Dobutamine Dextrose 0.8 mg/mL, 250 mL 40 mg/mL, 5 mL 250 mg 50 mg/mL, 5 mL Solution for Injection, Anp tle Solution for Injection, Amp ale Powder, Vial Solution for Infusion, Bottl.

Dopamine in 5% Dextrose 1.6 mg/mL, 250 mL Solution for Infusion, Bottl.

Epinephrine 1 mg/mL, I mL Solution for Injectior, Amp al.

Cough and Colds Preparations Butamirate Butamirate Levodropropizine Levodropropizine Butamirate 50 mg 7.5 mg/5 imL, 60 mL 30 mg/5 mL, 120 mL 30 mg/5 mL, 60 mL 7.5 mg/5 mL, 120 mL Sustained Release Tablet Oral Syrup, Bottle Oral Syrup, Bottle Oral Syrup, Bottle Oral Syrup, Bottle

Inhaled Corticosteroids / Antiasthma and COPD Preparations Beclomethasone 250 mcg/actuation, 200 Actuations Mctoredfose Inha

Beclomethasone + Formoterol 100 incg + 6 mcg/actuation, 120 Actuation: I Metored fiose Inhader

Beclomethasone + Formoterol 200 mcg + 6 mcg/actuation, 120 Actuations Metered Cose Inhaler

Budesonide Fluticasone Fluticasone + Formoterol Fluticasone + Salmeterol Beclomethasone + Formoterol + Glycopyrronium Budesonide Fluticasone + Formoterol 50 mcg + 5 mcg/actuation, 120 Actuations 100 mcg + 6 meg + 10 meg/actuation, 1%:0 200 mcg/actuation, 200 Actuations 200 meg/actuation, 300 Actuations 125 meg + 25 mcg/actuation, 120 Actuations 125 mcg/actuation, 120 Actuations 125 mcg + 5 mcg/actuation, 120 Actuations Actuations I Metered Dose Inhaler Metered Dose Inhaler Metered Dose Inhaler Metered Dose Inhaler etered Dose Luhalrr Metered Dose Intaler Metered Dose Inhale.

Fluticasone + Salmeterol 250 mcg + 25 mcg/actuation, 120 Actuations IMetered Dose Inhaler

Fluticasone + Salmeterol 50 meg + 25 mcg/actuation, 120 Actuatiorus Metered Dose Inhale

BUREAU OF INTERNAL REVENUE

f tiyr

JAN 10 2022 3 9:10 amJ UAU HroS mgt. DiviSiON

Intravenous and other Sterile Solutions

Acetated Ringer's 1 L Solution for Injerere / Ir usior. Bas Acetated Ringer's 1 L Bott {e Solution fer injesti n 7 ( usior)

Acetated Ringer's 500 mL Solution for Injection / tafusior., Ba. Acetated Ringer's 500 mL Solution for Inje ation / Infusior Bottle Balanced Multiple Maintenance Solution + 5% Dextrose Solution for Inie tion / Intusior. Ba:

Balanced Multiple Maintenance Solution + 5% Dextrose 1 Solution for Injection / Infusior. Bottle Balanced Multiple Maintenance Solution + 5% Dextrose 500 mL Solution for Inie atr an / Intusion. Bay

Balanced Multiple Maintenance Solution + 5% Dextrose 500 mL Solution for Inje -tion / Infusion. Bottle

Solution + 5% Dextrose Balanced Multiple Replacement Solution for Injerion / Intusion. Bay

Solution + 5% Dextrose Balanced Multiple Replacement L Solution for Inje -ion / Infusicon. Bott!e

Balanced Multiple Replacement Solution + 5% Dextrose 500 mL Solution for Inje tion / Infusion, Bag

Solution + 5% Dextrose Balanced Multiple Replacement 500 mL Solution for Inje tion / Infuston, Bottle Dextrose in Water Dextrose in Water 10%, 1L 10%, 1 L Solution for Injectior: / Infusion, Solution for Injet tion / Irfusicn, Bag Bottle Dextrose in Water 10%,500 mL Solution for Injeetion / Infusicn, Bag

Dextrose in Water 10%, 500 mL Solution for Injection / Ir:fision. Bottle Dextrose in Water 5% 1L Solution for Injection / irfusicn. Bae

Dextrose in Water 5%, 1 L Solution for Inje tion / Irf isicn. Bottle Dextrosc in Water 5%, 500 mL Solution for Injec tior / Irfision Bus

Dextrose in Water 5%,500 mL Solution for Injectior: / Irf isien Bottle Lactated Ringer's + 5% Dextrose 1 L Solution for Injex tirn / Irf sion B.ts

Lactated Ringer's + 5% Dextrose Lactated Ringer's + 5% Dextrose Lactated Ringer's + 5% Dextrose 500 mL 500 mL 1L Solution tor Injection / Itfusion Solution for Injec tion / Ir fusion. Bag. Solution for Injection /Irfusion Bottle Bottle Lactated Ringer's Solution 1 L Solution for Injecti n / Irfusion. Hag

Lactated Ringer's Solution 1L Solution f or Injiection / Ir fision Bottle Lactated Ringer's Solution 500 mL Solution for Injection / Infuston. Bag

Sodium + Dextrose Lactated Ringer's Solution 500 mL 0.3% + 5%, 1I Solution for IuiectionInfuaion Bal Solution for Injec tion / fnfnsion Bottle BUREAU OF INTERNAL REVENUE 1 TaNNT

RECORDS MGT.DIVISION OUI JAN 10 2022 4:10 am a TUU

Sodium + Dextrose 0.3% + 5%, 11 Solution for Injection / In usion. Bottle Sodium + Dextrose 0.3% + 5%, 500 mL Solution for Injection / In usion, Ba: . Sodium + Dextrose 0.3% + 5%, 500 mL Solution for Injection / In usion, Bottle Sodium + Dextrose 0.45% + 5%, 1 L Solution for Injesti on / Iatusior, Bas Sodium + Dextrose Sodium + Dextrose 0.45% + 5%, 1 L 0.45% + 5%,500 mL Bottle Solution for Injection / I nfusior. Bap. Solution for Inje ction / Intusior:

Sodium + Dextrose Sodium + Dextrose Sodium + Dextrose 0.9% + 5%, 1 L 0.9% + 5%,1 L 0.45% + 5%,500 mL Solution for Inje atisn / Infusior Solution for Inje tisn / Iifusion, Bat Bottle Solution for Inje tion / Infusior: Bottle Sodium + Dextrose 0.9% + 5%,500 mL Solution for Inje cti on / Infusio, Bag

Sodium + Dextrose 0.9% + 5%, 500 mL Solution or Inje irion / Infusion Bottle Sodium Chloride 0.9%, 1L Solution for Injestion / Infusion, Bas

Sodium Chloride 0.9%, 1 L Solution for Inje :tion / intusion. Bottle Sodium Chloride 0.9%,500 mL Solution for Injertion / In usion, Bas Sodium Chloride 0.9%, 500 mL Bottle Solution for Inje xion / Intusion.

Neuromuscular Blocking Agent

Atracurium Atracurium 10 mg/mL, 2.5 mL Ampule 10 mg/mL, 5 mL Ampule Solution tor Injecrion Solution for Inje: tion

Rocuronium 10 mg/mL, 5 mL Solution for Injection, Vinl

Suxamethonium 20 mg/mL, 10 mL Solution for Iajection, Vial

Vecuronium 10 ng Powder, Vial Vecuronium 4 mg Powder, Vial

Vasoconstrictor Norepinephrine 1 mg/mL, 10 mL Solution for Injection, Amptle Norepinephrine 1 mg/mL, 2 mL Solution fo- Injection, Ampule Norepinephrine 1 mg/mL, 4 mL Solution for Injeetiom, Ampt le Norepinephrine 2 mg/mL,4 mL Solution for Injection, Amptle

FOR DELISTING:

Interferon beta-1a 44 mcg syringe Solution for Injection, in prerilled

BUREAU OF INTERNAL REVENUE NT Ittyn.

RtCORRS MGIEVSION OCTCA JAN.10 2022 I:to amv

FOR MODIFICATION:

COVID-19 Vaccine under Emergency Use Authorization:

Sputnik V Gam-COVID- Vac COVID-19 Vaccine 0.5 ml Solution for Injection bit.lv PhFje SputV:a: y 2t

Whole Virion, Inactivated Corona Virus Vaccine [Covaxin] 6mcg NIV-2020 770 (strain Injection Solution for bit.ly/PhF] Covexin-! e

Monoclonal Antibodies / Immunosupressants

Casirivimab + Imdevimab Vial 120 mg/mL, 11.1 mL Vial 120 mg/mL, 11.1 mL Solution Infusion, Box fot bit.l/PhACasi-ds I7 NowDb 20 1

Casirivimab + Imdevimab 120 mg/mL, 2.5 mL Vial 120 mg/mL, 2.5 mL Vial + Infusion, for Box Solution bit.ly/PhirA.Cast tnd I7 Nowe D bet 20

Further, please be clarified that if the salt form of the medicines under the CCVI 19 V.AI Exermps List is not specified, it signifies that all the salt forms of the particular drig is co":red by the Va't exemption (i.e., for Meropenem Ig powder or 500 mg powder, the VAT-exerniptiot+ covers ail it: salt forms including sodium or trihydrate).

Pleasc see attached updated list of COVID-19 VAT Exempt List. Should there be ay Qu?:tions or clarifications regarding the updated list, please coordinate with Ms. "Vans sa s. Cbera at ysobera@doh gov.ph or Mr. Patrick D. Acuna at pdacuna@doh.goy.ph.

Thank you very much. ATTY. CHARADE B. MERCADO-GRANDE Digitally signed by Mercado- Date: 2021.12.22 15:35:01 Grande Charade Ballucanag t-0800

Health Regulation Team Undersecretary of Health

CC: ROLANDO ENRIQUE D. DOMINGO, MD Food and Drug Administration Director General

BUREAU OF INTERNAL REVENUE

7Yc

JAN 9:10 am 10 2022

0 S-mG1.0iV.S.0

LIST OF VAT EXEMPT DRUGS AND VACCINES PRESCRIBED AND DIRECTLY USED FOR COVID-1 S TR: :ATMI:NT y GenericNamcstnguvo ereacc Amphotericin B (Lipid Complex) 5 mg/mL,10 mL Suspension for Injection. Via1 Date HDFUAGSP

Ampicillin Ampicilin Ampicilin + Sulbactam Complex) Ampicillin + Sulbactam Azithromycin [Cefta zidime Amphotericin B (Non-Li pid Ampicillin Ampicillin + Sulbactam.. Azithromycin Azith romycin Azith romycin Aztreonam Aztreona m Cefazolin Cefepime Cefepime Ceftazidime Ampicillin + Sulbactam Azithromycin Azithromycin Azithromycin Azithromycin Azithromycir Cefepime Ceftriaxone Ceftriaxone Ceftriaxone Cefuroxi me Cefuroxime Cefuroxime Cefuroxime Cefuroxime Cefuroxime Cefuro xime Cefuroxime Cefuroxime Azithromycin Cefazoiin Cefotaxime Cefotaxime Ceftazidime Ceftria xone Cefuroxime Cefuroxime Cefuroxime Ciprofloxa cin izithr Cefotaxime Ceftriaxone Cefuroxime Cefuroxime Cefuroxime Cefuroxime Ciprofloxacin IVcit 50 mg 18 250 mg + 125 mg 50o mg h0o mg g.+ 500 mg. 200 mg/5 mL,15 mL 50o mg 250 mg 500 mg 2g+1 g 500 mg .250 mg. 200 mg/5 mL, 22.5 ml 200 mg/5mL, 30 mL 0 mg 50g oo mg 50o.mg 2g Lidocaine 250 mg 200 mg/5 mL,60 mL 250 mg 5oo mg g 500 mg 1g Ig 500.mg 1 g 1 g 500 mg 500 mg + 2 mL 1% Solution Of Lidocaine 125 mg/5 mL, 30 ml 125 mg/5 mL 60 ml 125 mg/5 mL, 70 ml 250 mg [250 mg Lg 28 Ig + 3.5 mL 1% Solution Of 250 m 1.5 250 mg/5 mL,70 mL 5oo mg 500 mg Ig 500 mg 1 125 mg 250 mg 250 mg/5 mL, 50 mL 250 mg/5 mL, 60 mL 750 mg 125 mg/5 mL,50 mL Oral Suspension, Bottle Oral Suspension, Bottle [Powder, Via] Oral Suspension, Bottle] [OraSpension, Bottle. [Powder Via] [Powder, Via] Powder, Via Powder, Via Powder, Vial Powder,Vial Powder, Via Film-Coated Tablet [Powder, Via Powder, Via! [Powder, Via] [Powder, Via Powder, Via] [Powder,Via] [Powder, Via] Powder, Via! Powder, Via Capsule Tahle Film-Coated Tablet Vial Powder, Via Powder, Vial Solution for Injection, Vial [Powder, Via] Powder Viat Table Powder, Via Powder, Vial Powder, Vial Solution for Injection, Via! Oral Suspension, Bottle Capsule Powder Vi al Powder, Via Powder, Via Tablet Oral Suspension, Bottle Oral Suspension, Bottle Qral Suspension, Bottle Oral Suspension, Bottie Oral Suspension, Bottle Oral Suspension, Bottle Film-Coated Tablet Tablet Film-Coated Tablet Film-Coated Tablet Powder, Vial Tablet 'ablet

Ciprofloxa cin 2mg/mL,100 mL Solution for Injection, Via Ciprofloxa cin 2 mg/mL, 200 mL Solution for Injection, Vial

Ciprofloxa cin Clarithromycin Ciprofloxa cin Ciprofloxacin Ciprofloxa cin Ciprofloxacin Clarithromycin Clarithromycin Clarithromycin Clarithromycin Clarithromycin Ciprofloxacin Clarithromycin Carithromycin 260 mg 250 mg 500 mg 5oo mg. 125 mg/5 mL, 60 mL 750 mg 125 mg/5 mL, 25 mL 2 mg/mL, 50 mL 125 mg/5 mL; 35 mL 125 img/5 mL. 50 mL 125 mg 125 mg/5 mL 70 mL 200 mg 200 mg Ora Suspension,Bottle Oral Suspension, Bottle Solution for Injection, Vial Oral Suspension, Botte Prolonged Release (PR) [Capsule Prolonged Release (PR) Film-Coated Tablet Oral Suspension, Bottle Oral Suspension, Bottle Tablet Tab let Film-Coated Tablet Dispersible Tabiet Film-Coated Tablet abie BUREAU OC INTERNAL REVENUE RECORDS *GI.DIVISIUN E and JAN 10 2022 9:10am C :n

LIST OF VAT EXEMPT DRUGS AND VACCINES PRESCRIBED AND DIRECTLY USED FOR COVID-19 TRHATMENT Generic Name --,-----.-:->----- a AnastheteAcA GaeraLEIn Estrengur you snoen ROmSWTERrecCH Da HNEUEAICSP

Kets mint 50 mg/ml..10 mL Solution for Injection. Viat Prspofo! 10 mg/mL,10 mL Solution fer Injection Ampule J[Propofal 10 mg/mL, 10 mL Solution for Injection, Vial

[P ropafel Propo{o 10 mg/mL, 20 mL 19 mg/mL, 29 mL Solution for (njection, Vial Solution for Injection. Ampule Propofa 10 mg/mL,50 mL Solution for Injectic uVia

pxycotione Fentang Fentany Frentany Fe [Fe anyt Morphine Morphinc Joxye ndone Oxoston Oxycodone Fent ang Fe n tany Morphine Morphine Morp hine Morphine DayenGoiLe Oxy codone Oxyc dene Dxyco iane Oxycodone Oxytodone Oxycodone Fentany] Fent anyt Amikacin Amikacin Amika cin Amikacin YMRIRNUREETENNYO y1 .-.... AMOPIO 5 180 mg 30 [i0 mg/mL, i ml. 30 m 401ag 5.ms/5 mL.250 ml 60 mg 23 m cg/hr 5o mcg/(hr 10 g 20 m 5 g 125 mg/mL, 2 mL 125 mg/mL, 2 mL 309 HCE 563 mcg/mL, 10 mL 50 mcg/mL,2 mL 10 m g i0 mg/mL, I mL 16 mg/mL. 1 mL 60 mg 10 g 10 mg/lmL,2 mL 100 mg/mL, 2 mL 100 mg/mL, 2 mL 100 cg 12.5 mcg/hi 200 mcg 400 mcg 10 g Acc jSublingua) Tablet Solution for Injection. Solution for Injection. Controlled-Release Tablet Sublingual Tablet Transderma! Patch Ampuie Modified Kelease (MR) Solution for Injection Controtied-Release Tablet Oral Solution, Bottle Solution for Injection, Vial Solution for Injection. Solution for Injection, Vial Sublingual Tablet Arnpule Tablet Tab}e Solution for Injection Tablet Controlled-Release Tablet_ Solution for Injection Solution for Injection. Controlled-Release Tabltt Controlled-Release Tablet Solution for Injection. Ampule Transdermial Patch Ampule Ampule Modified Kelease (MR) Tablet Ampule Ampule Capsule Controlled-Release Tablet Ampule 'ontrolled-Release Tablet ublinuatParlc ransderrial Patch :.::

Amikacin Amikacin 250 mg/mL,2 mL 250 mg/mL,2 mL Soiution for Injection, Vial Solution for Injection. Ampule

moxicilin Amoxicillin Amoxicillin Amoxicillin Amoxicillin Amikacin Amika cin Amoxicillin Amoxicillin Amoxicillin Amoxicillin Amoxicillin. 100 mg/mL, 10 mL [250 mg 500 mg 100 mg/mL,15 mL 125 mg/5 mL, 105 mL 125 mg/5 mL, 60 mL 250 mg/5 mL 105 mL 250 mg/5 mL,60 mL 5O mg/mL, 2 mL 50 mg/mL, 2 mL 250 mg 250 mg/5 mL.30 mL Oral Suspension, Bottle. Solution for Injection, Vial Oral Suspension, Bottle [Oral Suspenion Bottle {Capsule Oral Suspension, Bottle Oral Suspension, Bottle Oral Drops, Bottle Oral Drops, Bottle Capsule Dispersible Tablet Solution for Injection. Ampule

BUREAU OF INTERNAL REVENUE RECORDSGT.DIVISION NnrINT GT JAN 10 2022 9:10 am C

LIST OF VAT EXEMPT DRUGS AND VACCINES PRESCRIBED AND DIRECTLY USED FOR COVID- 9 'TRIRATMENT

Cla rithromycin Clarithromycin Clarithromycin Clarithromycin Clindamyci Clindamyci n Clarithromycin Clarithromycin Clarithromycin Clarithromycin Clarithromycin CGeneric Namea MEsStrnhaaEornARanCu 50o mg 50o mg 250 g [500 mg 250 mg 250 mg/5 mL. 25 mL 250 mg/5 mL 50.mL 500 mg 150 mg 150 mg/mL, 2 mL 250 mg/5.mL: 79 mL [Ora Suspension, Bottle Oral SuspensionBottle Extended Release (ER) Tablel Solution for Injection. Table Oral Suspension, Bottie Film-Coated Tabiet Modified Release (MR) Tablet Capsule Ampule Tanlet ilm-Coated Table oe IERUEUAJGSP

Clinda mycin 150 mg/mL.2 mL Solution for Injection, Vial

Co-Amoxiciav(Amoxicilin Potassium Clavula nate) [Potassium Clavulanate) [Potassium Clavulanate) Clindamg Potassium Clavulanate Co-Amoxiciav (Amoxicillin Co-Amoxiclav (Amoxicillin Potassium Clavulanate). Clindamycin Clindamye Co-Amoxiclav (Amoxicillin C Co-Amoxiclav (Amoxicillin + Co-Amoxiclav(Amoxicillin Potassium Clavulanate) 2c D 0-Amcxiciav (Amoxicillin otassium Clayulanate tassium Clavulanate -Amoxiclav (Amoxicillin assium Clavulanate moxiclav (Amoxicillin 150 mg/mL, 4 mL [75 mg/5 mL 60 mL j125 mg + 31.25 mg/5 mL, 30 mL {200 mg + 28.5 mg/5 mL, 100 mL [200 mg + 28.5 mg/5 mL, 60 mL J1 g + 200 mg [125 mg + 31.25 mg/5 mL, 60 mL 200 mg + 28.5 mg/5 mL, 70 mL 250 mg + 125 mg 300 mg 125 mg + 31.25 mg/5 mL, 100 mL 250 img + 125 mg Oral Suspension, Bottle Oral Suspension, Bottle Oral Suspension, Bottle Oral Suspension, Bottle Solution for Injection. Capsule Powder, Via! OralSuspetsion Bottle Oral Suspension, Bottle Oral Suspension, Bottle Tab let Ampule Film-Coated Tablet rr-.-.-..

Co-Amoxiclav (Amoxicillin + Potassium Clavulanate) Co-Amoxiclav (Amoxicillin + otassuunm (avuanate 250 mg + 62.5 mg/5 mL, 100 mL 250 mg + 62.5 mg Oral Suspension, Bottle Dispersible Tablet

Co-Amoxiclav (Amoxicillin + Potassium Clavulanate) Potassium Ciav tassium Clavulanate) -Amoxiclav(Amoxicillin + tassium Clavulanate) -Amoxiclav (Amoxicillin -+ Amoxiclav (Amoxicillin ulanate) 250 mg + 62.5 mg/5 mL, 60 mL 400 mg + 57 mg/5 mL, 35 mL 400 mg + 57 mg/5 mL, 70 mL 400 mg + 57 mg/5 mL, 30 mL Oral Suspension, Bottle Oral Suspension, Bottle Oral Suspension, Bottle Oral Suspension, Bottle

Co-Amoxiclav (Amoxicillin + tassuuit Iay Jauatel 500 mg + 100 mg [Powder, Via]

Potassium Clavulanate) Co-Amoxiclav (Amoxicillin + -Amoxiclav(Amoxicillin + o-Amoxiclav (Amoxicillin tassium.Clavulanate) i13f 500 mg + i25 mg 500 mg + 125 mg 600 mg + 42.9 mg/5 mL, 100 mL Film-Coated Tablet Tablet Oral Suspension, Bottle

Cotrimoxazole (Sulfamethoxazole + Trimethoprim) Cotrimoxa zole (Suifamethoxazole+ Trimethoprim) Potassium Clavulanate) Cotrimoxazote (Sulfamethoxazole + Trimethoprim Potassium Clavulanate) Cotrimoxazole (Sulfamethoxazole + Trimethoprim) Cotrimoxazole (Sulfamethoxazole + Co-Amoxiciav (Amoxicillin + Co-Amoxiclav (Amoxicillin + Potassium Clavulanate) Colistin Cotrimoxazole (Sulfamethoxazole + Cf Trimethoprim Co-Amoxiclav (Amoxicillin + Co-Amoxiclav (Amoxicillin + tassiurm Clavulanate) imethoprim imethoprim trimoxazole (Sulfamethoxazole + 875 mg + 125 mg 600 mg + 42.9 mg/5 mL, 70 mL 200 mg + 40 mg/5 mL, 60 mL 600 mg + 42.9 mg/5 mL, 50 mL 875 mg + 125 mg 2,000,000 200 mg + 40 mg/5 mL, 120 mL 200 mg + 40 mg/5 mL, 70 mL 400 mg + 8o mg 400 mg + 80 mg 400 mg + 80 mg/5 mL, 60 mL 800 mg + 160 mg [Oral Suspension, Bottle Powder, Viat Oral Suspension, Bottle Capsule Oral Suspension, Bottle Tab let Oral Suspension, Bottle Oral Suspension, Bottie Tablet Oral Suspension, Bottle Tablet Film-Coated Tablet BUREAU OF INTERNAL REVENUE TNTTTNT

RECORDS GT.DIVISION GUG JAN 10 2022 9:10 4 T

LIST OF VAT EXEMPT DRUGS AND VACCINES PRESCRIBED AND DIRECTLY USED FOR CO'V! D-18 TR: :AT'M1:NT

Erythromycin Trimethoprim Doxycycline Erythromycin Erythromycin Erythromycin Erythromycin Erythrontycin Cotrimoxazole Suifamethoxazole + Erythromycin Erythromycin Genta micin Gentamicin Gentamicin Levofloxa cin Ertapenem Levofloxa cin Levofloxacin GenerioNamestenh or Reerenco T 200 mg/5 mL, 60 mL [250 mg 125 mg/5 mL, 60 mL 20 mg 250 mg 800 mg + 160 mg 100 mg 200 mg/5 mL 30 ml 250 400 mg/5 mL, 60 mL 500 mg 10 mg/mL, 2 mL 40 mg/mL,2 mL 5 mg/mL,100 mL 18 500 mg 40 mg/mL,2 mL Film-Coated Tablet Oral Suspension, Bottle Solution for Injection, Vial Oral Suspension, Bottle Film-Coated Tablet Ampu!e Solution for Injetion, Vial [Film-Coated Tablet Oral Drops, Bottle Solution for injection. Solution for Injection, Tablet Capsule Powder, Vial Tablet Ora Tablet Ampule Im-Coated Tablet 1 Suspension, Bottie Dae DENEOIGP

Levofloxa cin 5 mg/mL, 150 mL Solution for Injection, Via!

Metronidazole Penicillin G Benzathine (Benzathine Penicillin G Crystalline] Levofloxacin Levofiox a cin Linezolid Meropenem Meropenem Metronidazole Metronidazole Oxacillin Qxacillin Oxacillin Benzylpenicllin) Levofloxacin Linezolid Linezolid Penicillin G Crystalline Pipera cillin + Tazobactam Hyos cine Hyoscine Levofloxacin Linezolid Metronidazole Metronidazole Vancomycin Hyoscine Hyoscine evofioxaci Vancomycin iperacillin + Tazobactam B EEN N TTENEOWR Whmnho 5 mg/mL, 50 mL o g 2 mg/mL, 300 mL [6oo mg 125 mg/5 mL, 60 mL g 100 mg/5 mL, 150 mL 500 mg 750 mg 2 mg/mL,300 mL 500 g 250g 5 mg/mL, 100 mL 50o mg 250 mg [4g+590 mg 5 mg/5 mL, 120 mi 750 mg 500 mg 500 mg 500 mg to mg 10 mg 20 g 20 mg/mL, i mL 1,200,000 Units 1MU 5MU 2 g + 250 mg O ENRNACYS Solution for Injection, Vial [Tablet Oral Suspension Bottle [Powder, Via Powder, Vial [Film-Coated Tablet [Film-Coated Tablet [Powder, Via] [Tablet [Powder Via] alan Film-Coated Tablet Oral Suspension, Bottle Solution for Injetion, Vial Film-Coated Tablet Powder, Via! Powder, Vial Bottle Powder, Via Powder, Vial Tahle Solution for Infusion, Bag . Solution for Infusion Tablet Powder, Vial Powder,Via] Powder, Vial Film-Coated Tablet Oral Syrup, Bottle Tablet Solution for Injection. rablet Ampule wder.Y h yrup: Bot s LacYHb oMe W WsW E T

Aspirin Aspirin Aspirin Aspirin. Clopidogrel Clopidogrel Aspirin Aspirin Aspirin Aspirin Loo mg 32g mg Bo g 8o mg [300 mg 300mg 80 mg 75 mg 8o mg Enteric-Coated Tablet [Delayed Release (DR) Capsule Enteric-Coated Tablet [Film-Coated Tablet Capsule Tablet Tablet Tablet Tablet Tablet Film-Coated Tablet

BUREAU OF INTERNAL REVENUE

NNTIYNT

JAN 10 2022 : toamm 4

FC AECOEDS MGI.DIVISIN

LIST OF VAT EXEMPT DRUGS AND VACCINES PRESCRIBEDAND DIRECTLY USED FOR COVID-ISTR HTMNI

Levodropropizine Butamirate Butamirate Butamirate Levodropropizine SGeneric Namesy . wwnLneawYssrEnmm.oea m - [2.5 mg./5 mL., 60 m] Ceawaoacouh 50 ng 30 mg/5 mL,120 mL 7.5 mg/5 mL.120 mL 30 ng/5mL60ml asrenTrwyaaN [Oral Syrup Bottle OralSyrup,Iotte Sustained Rclease Table Oral Syrup,Bottle O Rot EX N SRTe a 1on22 ye DRUEUATS

Fluticasone + Forinotero Budesonide COS feclomethasons Beclomethasone + Formoterol interferon beta-1a Beclomethasone + Formotero! Beclomethasone + Formoterot + Budesonid luticasone yoyrroniun Coo Actuationg i00 meg + 6, meg,+ 10 meg/actuation. I20 Actuations. I25 mcg/actuation, 120 Actuations.[Metered Dse Inhaler 250 mcg/acttation, 200 Actuatiors. Metered Dose Inhaler Actuations 200 mcg/act uation, 200 Actuations Metered Dose Inhaler 209 mcg/actuation. 300 Actuations Metered Dose Inhaler 44 mcg 100 mcg +6 rnce/actuation,120 200 meg + 6 mcg/actuation,120 125 mcg + E mcg/actuation.120 ctuaticr 1.Metered Dose Inhaler [Metered Dose Inhaler Metered Dose Inhaler Metered Dose Inhate Solution for Injection, in Drefilled syring

Fluticasone + Salmeterol Fluticasone + Formoterol 50 mcg + 5 mcg/actuation,120 Actuations 125 ricg + 25 mncg/actuation xctuations 1.120 Metered Dose Inhaler Metered Dose Inhaler

JAcetated Ringer's Balanced Multiple Repiacemen Balanced Multiple Replacemen Fluticasone + Salmeterol Fluticasone + Salmeterol Acetated Ringer's Acetated Ringer's Solutitn + 5% Dextrose. Solution Solution + 5% Dextrose Dextrose in Water Dextrose in Water Lactated Ringer's + 5% Dextrose Lactated Ringer's Solution Balanced Multiple Maintenance Solution + 5% Daxtrose Balanced Muitiple Maintenancr Balanced Multiple Maintenance Solution + 5% Dextrose Batanced Multiple Replacement Solution + 5x Dextrose Dextrose in Water Dextrose in Water Dextrosc in Water Dextrose in Water Dextrose in Water Dextrose in Water Lactated Ringer's + 5% Dextrmse WENGOHGH Acetated Ringer's Solution + 5% Dextros Balanced Multiple Replacement actated Ringer's + 5% Dextross olution + 5% Dextros tated Ringer's + 5% Dextrose Iiced Multiple Maintenance Dextrose 5 [500 m [5%, 500 m L IL [50 meg + 25 mcg/acluation. 120 500 mL 500 mL [5%.1L 1L [I 1L L 1o%, 1 10%, 1 10%, 500 mL 10%. 500 mL 5%, 500 mL 500 mL Actuations 500 m 500 mL 500 m 500 m I I Actuaticn 250 mcg + 25 mcg/actuation.120 Y HInfusion, Botte Infusion, Botte Sotution for Injection / Solution for Injection ] [nfusion, Bag [Solution for Injection] infusion, Ba Solution for Injection Infusion. Bag Infusion, Bottie Infusion, Bottle Infusion, Bay Infusion, Bottle Solution for Iniection 7 Solution for Injectior Infusion, Bag Infusion, Bottle Infusion, Ba nfusion, Botrle Infusion, Bag Solution for Injection / Solution for Injection / Infusion, Bottle Sclution for Injection 7 Solution for Injection : Infusion, Bag Infusion, Hottle Solution for Injection 7 Infusion, Bottle Solution for Injection / Infusion Bag Infusion,Bot tle Solution for Injection / Infusion, Bag Solution for Injection ) Solutton for Injection / Solution for Injection / Infusion,Bottle Inf Solution for Injection j Solution for Injection / Solution for Injection Infusion, Bag Solution for Injectinn / Solution fot Injection / Solution for Iniection / Solution for Iniection / Intusion, Ra Solution for Iniection Solution for Injection t Metered Dose Inhaler sion Bag red Dose Inhaler RURE AU OF INTERNAL REVENUE CaTIYYNT

JAN 10 2022 WUS-MGT.DIV+S+ON 9:io amU c

LIST OF VAT EXEMPT DRUGS AND VACCINES PRESCRIBED AND DIRECTLY USED FOR COVID-1S TR TMINT

Wa rfarin Clon a ze pam Diazepa m War(a rin Clona zepsa m Diazepam Diazepam Hepa rin Tinzaparin Warfarin Clopidogrel Clopidogrel Dalteparin Sodiurn Enoxaparin Enoxa parin Enoxaparin Fondaparinux Heparin Tinzaparin Tinzaparin Enoxaparin TOREET Generic Name aNrenstrnguy? [5g 5 mg/mL, 2 ml I75 mg 5000 IU/mL, 5 mL 10,000 Anti-Xa [U/mL, 2 mL E mg 100 mg (10,000 IU)/mL, 0.4 mL 100 mg (10,000 IU)/mL, 0.8 mL 2.5 mg/0.5 mL, 0.5 mL 1000 IU/mL,5 mL 10,000 Anti-Xa IU/mL, 0.35 mL 10,000 Anti-Xa IU/mL, 0.45 mL 500 g Eig 2.500 IU/0.2 mL, 0.2 mL 100 mg (10,000 IU)/mL, 0.2 mL 100 mg (10.,000 IU)/mL, 0.6 mL 2.5 mg 5 mg 2 mg 4o mg VCO A .c. Tablet [Tablet Film-Coated Tablet. [Filled Syringe [Solution for Injection. Pre Solution for Injection, Vial [Solution for [njection, PreFDA Circular No. 202 Filled Syringe fTablet Solution for Injection, Pre- Solution for Injection, Pre- Filled Syringe Solution for Injection, Pre- Filled Syring Filled Syring Solution for Injection, Vial Tablet Table. Tablet Solution for Injectinan. Table Filled Solution for Injection, Pre. Filled Syringe Solution for Injection, Vial Solution for injection, Pre-] Annulc or Syrine FDACircular No. 2021 FDA Circular No.202- FDA Circular No. 20z FDA Circular No. 2021 008 008 008 008 D00 008 2 S:ptemler 2021 2S :ptemher 202 2 S spteml ier 2021 2 S zptenher 2021 2S utcm 2 S ptemher 20 . Date er20 -+-.- IDEGSP Y

Midazolam Midazolam. Midazolam [Midazoian_ Micla zolam Midazolam Midazolan - ,-x 15 n 1 mg/mL,5 mL 1mg/mL, 5 mL 35 mg 5 mg/mL,3 mL 1 mg/mL, 3 mL 5 mg/mL.1 mL HGNaRAnur u ZAno H TH Solution for Injection Solution for Injection Solution for Injection, Film-Coated Tablet Solution for Injection. Ampule Solution for (njection, Vis] Table g Ampule In D}

Iwermectin Haloperidol Haloperidol Vasopressin ENEN 2----,,--,--: SA ATheLABeD ZUINI 2O IU/mL,1 mL 20 mg 5 n Tablet Solution for Injection. Tablet Tablet rrrle :

Haloperidol Ha loperidol .* A 5 mg/mL, 1 m 50 mg/mL.1 mL Soiutior for Injection Solution for Injection. Ampuls mnu

Remdesivir Favipiravir Faripiravir Favipirayir 1400 mg oo m 200 00g Tablet Tablet Tablet Powder, Via I

Remdesi r ,.- CHEE T 5 mg/mL.20 mL Solution for Injection, Vial

Dsbutamine Epinephring Dobutatnine Dobutamirt Dopanine Dopamine in 5% Dextrose Dobutamire Dopamine ra 12.5 mg/mL., 29 mL 50 ng/ml.. 5 mL 25 mg/mL, 10 mL 250 mg 40 mg/mL,5 mi. t.6 mg/imL, 25(} mL D.8 mg/ml., 250 mL. I mg/mL, I mi Solution for Injection, Solution for infusior. Bottle Ampule Solution for Infusion, Vial. Powder, Via! Solution for Injection, Solution for Infrision. Solution for Injection. Ampule Ampule Solution fer Injection Ampule Bottle BUREAU OF INTERNALREVENDE

NnnYYTT M

RECORDS WGT.DIVISON ACU JAN 10 2022 1:1oam

Sodium + Dextrose Sodium + Dextrose Sodium + Dextrose Baricitinib Baricitinib Baricitinib Baricitinib. .. Leron limab Tocitizurmab Atracuriun Lactated Ringer's Solution Sodium + Dextrose Sodium + Dextrose Sodinm + Dextrose Sodiun + Dextrose Sodium Chloride Sodium Chloride Casinvimab + Imdevirnal Tociliz imab Tocilizumabf Tocilizumah Atraturiun Laclated Ringer's Solution Lactated Ringer's Solution Sodium Sodium + Dextrose Sodium + Dextrose Sadium Chloride Casirivimah + Indevimab S+dium+ Dextrost HSRNNOAWENRECH BONARN Y odium Chioride diunt + Dextross: Erv Generic Nane Merdke MoDconaAbodh Dextrose LIST OF VAT EXEMPT DRUGS AND VACCINES PRESCRIBED AND DIRECTLY USED FOR COVID-19 TRFATMENT mg/mL.2.5 mL Via 0.3% + 5%. 1 L 0.3% + 5%. 500 mL 0.9% + 5%, 500 mL 0.9%,500 mL B50 20 mg/mL, 20 rmL o mg/mL,5 mLAmpule TEUSUOANN N POREMEY TRYD U" 0.3% + 5%, 500 InL Q.45% + 5%, 1 L 0.9% + 5%, 1 0.9% + 5%. 500 mL (.9%, 1 L 120 mg/mL, 11.1 mL Vial + 120 120 mg/mL. 2.5 mL Vial + 120 162 mg/0.9 mL, 0.9 mL 20 mg/mL,i0 mL 500 m L 500 mL 0.3%+ 5X,1 L 0.45% + 5%, 1 L 0.45% +5%. 500 mL 0.9% + 5%, 1 L 0.9%, 1 L 0.9%, 500 mL 2 mg 2 mg 4 g mg/mL, 11.1 mL Vial 20 mg/mL,4 mL 1o ng/mL, 2.5 mL Ampule 0.45% + 5%,500 mL 4 mg y [Solution for Injection ] Sclution for Inje:ction / Infusion Bottle Solution for Injection / Solution for injection / [filled Syringe Solution for Injectiou Solution for Injection ] Infusion, Bag Infusion, Hottle Solution for Injection / Infusion, Bottle Solution for Injection / Solution for Injection, Solution for Injection / Sotution for Iniection Infusion, Bottle Solution tor Injectioa InfusionBottie Infusion, Ba Solution fo Film-Coated Tablei Film-Coated Tablet Solution for Infusion, Box Solution for Infusion, Box Solution for Injection,Vial Solution for Injection, Pre- Solution for Infusion, Vial Solution for Infusion, Vial Solution for Injection ] Solution for Injection ? Intusion, Bag Solution for Injection InfusionBa Infusion,Hag Solution fot Injection InfusionBag Tablet Tabiet Solutior for infusion, Vial Solution for Injectinn InttsionKotrte Infusion. B. Sclution for fnjection / Infusion, Bott! Infusion, Bottle Solutior for iniection Solution for Injection uficicnB Fusion, Bottle fusionHa Injection . hit.ly/PhFDA-Casi-1m ie FDA Circular No. 2020 FDA Circular No. 2020- pit.ly/PhFDA-Casi-Im+ts FDA Circular No. 202. FDA Circular No. 202.1 012- 012-A 01 17::ovember 2021 H ThDacE 1v 2J April 2020 :7 uly 2020 7Jtly 2020 7 July 2020 Der 2021 A: HEDEUEUACSP

Rocuronium 10 mg/mL,5 mL Solution for Injection, Via

Vecuronitm Dexamethasone Suxamethonium Dexamethasone Vecuroniun Dexamethasone Dexamethasone .. PEpsytemicCorueonroluILiN IEE j4 mg/mL,1mL 3 mg o mg 2 mg/mL,2 mL 20 Ing/mL, 10 inL 1mg Solution for Injection. Vial Solution for Injection. Solution for Iniection Powder, Via Ampule Tabiet Ampule Powder, Via Tabl .:

Dexamethasone Dexamethasone 4 mg/mL,1 mL 4 mg/mL,2 mL Solution for Injection, Via! Solution for Injection. Ampule Dexamethasone Dexamethasone 4 mg/mL, 2 mL 5 mg/mL, 1 mL Solution for Injection, Vial Solution for Injection, Ampule RURFAUOFINTERNALREVEN RnRTTN

JAN 10 2U?? 10 am

RECOROS MGT.DIVIS!. C

LIST OF VAT EXEMPT DRUGS AND VACCINES PRESCRIBED AND DIRECTLY USED FOR C(V! D-1 TR 'TMFNT GenericNamt Nroah TOS RGenea A DEUEUACP Dexamethasone 5 mg/mL, 100 mL Solution for Injection, Via! Dexamethasone 50 mg/mL,1mL Solution for Injection, Amnule Dexamethasone 500 cg Tabte Dexamethasone. Norepinephrin. Norepinephrine Norepinephtine Norepinephring 750mcg 1 mg/rnL,2 mL 2 mg/mL,4 mL I mg/mL, 10 mi i mg/mL,4 mL NNN Ampule Solution for Injection. Solution for Injection, Solution for Injection, Ampule Solution for Injection.t Ampule Amipule h VOO

*Volut mes of liquid preparations are expressed as net content DEU: Drug Emergency Use Authorizatior EUA: Emergency Use Authorization CSP: Compassionate Special Pemit List of medicines was based on the current Philippi F rMicrobioog It asesPsMDCU and re Proesionals Aliance An

tiec3}Y ae0ftnusas0fis

BUFEaU OF INTERNALREVENUE N 7775T

E+CUADS +GT.DIVIS.: :. VT JAN,10 2022 G:10am

COVID-19 Vaceine (Vero Cell) tnact ivate: COVID-19 Vaccine (Vero Cell}) ChAdOx1-S(recomhinant] (COVID- Vaccine AstraZeneca COVID-19 m RNA Vaccin Vaccine Moderna C:OVID-19 Vaccine {Vero Cell) Indctiy. Binopharm] Inactivated [COVID1gVaccine tnucleost Sitphsrm(Wuha yoLtam ikeue . N -*: -19 Vaccine SARS-CoV-2 rS Genetic Name de modified} {COVID-19 i[COVID-19 Vaccime [COVID-19 Varcine ticle Vaccine NHGENCOVD1YACCOT LIST OF VAT EXEMPT DRUGS AND VACCINES PRESCRIBED AND DIRECTLY USED FOR COVI0-19 TREATMENT O.Em 0.5 m. (.5 m 0.5 m 5 n 00 mcg twStrengthrewn FOCO Solution for Injection Suspension for injection Suspension for Injectior Suspension for Injection Suspension for injection Suspension for Injection] hit.ly/PhFDA-sinopham hit.ly/PhfDAsinorhdY hiy/PhFA-inorhau bit.ly/PhFIA-Modora bit.ly/PhFD-Coywy bit.ly/PhkbaAstra N T 10 -epember 20:1 17 :oem:er 20:1 2& Jaun(iary 202) it August 2021 Dae 3 May 2021 Jute 202: DEUEUXGSP

JJanssen C(VID-19 Vacine (BNT162b2 SARS-CoV- Vaccine (Vero CelD) Whole Virion, Indctivated Corong Pfizer-BioNTech COVID-19 Vaccine 19Vaec uactivated [Coronavac] rus Vaccine [Caxin] D.cOV2-S(recomhinant) ti- V Garn-COVID-Vac COVID- [30 mcg 600 SU/0.5 mL 5 x 1010 virus particles (VP) 0.5 m 6meg (strain NIV-2020-770 [Suspension for Injection [Suspension for Injection] Suspension for Injection Soiution for Injection Solution for Injection Dit.l/PhFDA-Cova(n bit.ly/PhFDA-Jansse: bit.ly/PhFDA-SputV-:1 bitJy/PhFD-Pfire! bit.ly/PhFDA-Sinova 14 Jandary 202: 22 Fehruary'202 : 9 Aprif 2021 8 Ju;y' 2021 1 Ju& 2021

BUREAU OF INTERNAL REVENUE RECORDS MGTDIVISN NaTyN U JAN 10 2U22 :10.90M CA